Extrapyramidal symptoms in psychiatry — diagnosis and treatment

Abstract

Introduction to the treatment of second generation antipsychotics (SGAs) meant that in recent years has often raised the importance of such treatment complications associated with their drug use, such as weight gain, diabetes and metabolic syndrome. It should be emphasized that, with the occurrence of drug-induced extrapyramidal symptoms could be the case for both the first and the second generation of neuroleptics. It is estimated that drug-induced extrapyramidal symptoms, may be present in varying degrees in up to 50% of patients treated with psychotropic drugs, wherein one patient, symptoms belong to different groups such as drug-induced parkinsonism, dystonia, akathisia, and dyskinesia.